SABR PRIMER - Evaluating Stereotactic Ablative Radiotherapy for Primary and Regional Breast Tumors
Clinical trial NCT06937281 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06937281
- Sponsor
- British Columbia Cancer Agency
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-01
- Primary completion
- 2029-06-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.